Skip to content

OCRA’s International Gynecologic Cancer Conference

OCRA’s International Gynecologic Cancer Conference®

The largest conference dedicated to the gynecologic cancer community. Free and open to all.

September 16-17, 2026 | Online and free to attend | Register Today

OCRA’s International Gynecologic Cancer Conference is the largest online event dedicated to education, support, and connection for those impacted by ovarian, endometrial, cervical, and other gynecologic cancers—bringing the experts to you, wherever you are.

This year’s conference offers dedicated programming for ovarian, endometrial, cervical, and rare gynecologic cancers, so you can spend your time on the updates and conversations that speak directly to your experience. And for the first time, each of these diagnoses has its own individual Ask the Experts session.

Join us to learn from the top clinicians, hear what’s on the horizon in clinical trials, and connect with a community that understands.

Whether you’re newly diagnosed, in treatment, off treatment, or supporting someone you love, there’s a place for you here.

Register for Conference

Conference Agenda

Agenda is current as of August 10, 2026 and is subject to change. All times are listed in EDT (Eastern Daylight Time).

  • Welcome and Opening Remarks
    (11:00 am – 12:15 pm)
    -Audra Moran, OCRA’s President & CEO
  • Ask the Experts (Dedicated Sessions)
    (1:00 pm – 2:30 pm)
    In these four dedicated sessions, our live panels of experts answer your important questions about research, treatment, and survivorship specific to diagnosis of ovarian, endometrial, cervical, or rare gynecologic cancer.

    • Ovarian Cancer
      -Kevin Elias, MD
      -Ursula Matalonis, MD
      -Oladapo Yeku, MD, PhD, FACP, FASCO
    • Endometrial Cancer
      -Vickie Bae-Jump, MD, PhD
      -Stephanie Gaillard, MD, PhD
      -Tarik Silk, MD
    • Cervical Cancer
      -Steven Holloway, MD
      -Leslie Randall, MD
      -Ana Tergas, MD
    • Rare Gynecologic Cancers
      -Jubilee Brown, MD
      -Amanda Fader, MD
      -John Farley, MD
  • The Role of Lifestyle and Caregivers in Your Cancer Care – Moving, Eating, and Caring Well
    (2:30 pm – 3:30 pm)
    -Shannon Armbruster, MD, MPH
    -Abigail Zamarano, MD, MPHS
  • Talking Clinical Trials (Dedicated Sessions)
    (3:30 pm – 4:00 pm)

    • Ovarian Cancer
    • Endometrial Cancer
    • Cervical Cancer
    • Rare/Tumor Agnostic Gynecologic Cancer
  • Easing the Burden: Symptom Management for Gynecologic Cancer
    (4:30 pm – 5:30 pm)
    -Lisa Landrum, MD, PhD
  • Community Connections
    (5:30 pm – 6:30 pm)
    -OCRA Support and Education Team
  • Reflections
    (10:00 am – 11:00 am)
    -OCRA Support Team
  • Dedicated Sessions
    (11:00 am – 12:00 pm)

    • Ovarian Cancer: Managing Ovarian Cancer Recurrence
      -Sarah Adams, MD
    • Endometrial Cancer: Managing Endometrial Cancer Recurrence
      -TBA
    • Cervical Cancer: Radiation Therapy Updates and Advances
      -Lillie L. Lin, MD
    • Rare Gynecologic Cancers: LGSOC and Borderline Ovarian Tumor Updates
      -Beryl Manning Geist, MD, FACOB
  • From Bench to Bedside Panel: How Do We Go From Research to Treatment?
    (12:00 pm – 1:00 pm)
    This session will discuss the process of translating scientific discoveries into new cancer treatments, how findings from laboratory research are used to develop new interventions, and how these are tested, evaluated, and then integrated into clinical practice.
    -Alessia Baccarini, PhD
    -Roisin O’Cearbhaill, MD
    -Madeline Merrill, MSN, AGNP-BC
    -Dmitriy Zamarin, MD, PhD
  • FDA Listening Session
    (1:00 pm – 2:00 pm)
    This special session is an opportunity to ask questions about the FDA’s role in drug development and approval, learn how patient perspectives inform decision-making, and help shape the future of gynecologic cancer care. The panel will answer questions submitted in advance as well as live questions from attendees.
    -Michelle Olson, FDA
    -Christy Osgood, FDA
  • Navigating Survivorship
    (2:00 pm – 3:00 pm)
    -Jill Aldredge, MD
  • Talking Clinical Trials
    (3:00 pm – 3:30 pm)

    • Talking Clinical Trials: Ovarian Cancer
    • Talking Clinical Trials: Endometrial Cancer
    • Talking Clinical Trials: Cervical Cancer
    • Talking Clinical Trials: Rare/Tumor Agnostic Gynecologic Cancer
  • Talking through Tough Moments: Navigating Difficult Conversations
    (3:30 pm – 4:30 pm)
    -Rachel Montague, FNP-C, PMHNP-BC, ACHPN
  • Keynote Conversation
    (4:30 pm – 5:30 pm)
  • Closing Remarks
    (5:30 pm – 6:00 pm)
  • Community Connections
    (6:00 pm – 7:00 pm)
    -OCRA Support Team

Don’t miss these highlights!

The Role of Lifestyle and Caregivers  in Your Cancer Care: Moving, Eating, and Caring Well
Discover how nutrition, physical activity, and caregivers can support well-being during and after treatment for both patients and loved ones. Bring your questions for a live Q&A with the experts.

FDA Listening Session
Join leaders from the U.S. Food and Drug Administration (FDA) for an interactive conversation about living with gynecologic cancer. Share your experiences with diagnosis, biomarker and genetic testing, treatment decisions, side effects, quality of life, and the challenges you’ve faced along the way.

From Bench to Bedside: How Research Becomes Treatment
Gain a better understanding of how scientific discoveries move from the laboratory to clinical trials and ultimately become standard treatments. Experts will also discuss the patient treatment experience and the important role clinical trials play in advancing care.

Ask the Experts: Ovarian, Endometrial, Cervical, and Rare Gynecologic Cancers
Choose from four diagnosis-specific expert panels offering in-depth discussions on treatment options, research advances, biomarker testing, survivorship, side effect management, supportive care, and more. Submit your questions in advance or ask them live during the sessions.

Navigating Survivorship
Explore practical strategies for living well beyond diagnosis, with guidance on emotional well-being, physical health, sexual health, and finding the support you need throughout survivorship.

And much more, including dozens of educational sessions, inspiring stories, interactive discussions, and opportunities to connect with a compassionate community that truly understands the gynecologic cancer experience. Join us!

Conference FAQs

OCRA’s International Gynecologic Cancer Conference is the largest and longest running conference focused on ovarian cancer, now with expanded sessions for those affected by gynecologic cancers. The conference brings together patients, caregivers, survivors, advocates and friends to learn about the latest developments in research, diagnosis, treatment and quality of life. All members of the gynecologic cancer community are welcome. Opportunities are also available for sponsorship.

Yes, this is the same annual conference. We have updated the conference name to reflect all the sessions, support and resources offered for those facing ovarian cancer, as well as the broader gynecologic cancer community.

OCRA’s conference is held online, so anyone from anywhere can join.

OCRA’s International Gynecologic Cancer Conference is free for all attendees.

If you registered for the Conference, you can continue to log in to watch sessions. Videos will be posted on OCRA’s website in the coming weeks.

Please view our sponsorship prospectus to discover opportunities for your company/organization to support the International Conference. For questions or more information on sponsorship opportunities, please contact elizabeth@meetingexpert.org.

We are happy to answer any questions you have. Just email conference@ocrahope.org or call (212) 268-1002 and our conference team will assist you.

Our 2026 Sponsors

OCRA’s International Gynecologic Cancer Conference would not be possible without the generous support of our sponsors. Interested in sponsoring OCRA’s International Conference? View sponsorship details or contact elizabeth@meetingexpert.org.

Presenting Sponsor

Lilly

Advocate Sponsor

Supporter Sponsor

Corcept Therapeutics logo
Genmab logo
Regeneron Science to Medicine logo
Verastem Oncology
Rentals

Sponsorship Opportunities

OCRA’s International Gynecologic Cancer Conference is the largest and most trusted conference devoted to the ovarian and gynecologic cancer community. It is the epicenter for researchers, clinicians, survivors, and friends to come together and learn from one another about developments in diagnosis, treatment, and quality of life for women with ovarian or gynecologic cancer.

Through your sponsorship, you play a key role in alerting women to the risk factors of ovarian cancer, helping researchers learn how better to screen and treat the disease, and giving power to ovarian cancer survivors’ voices. Together, we can work to bring awareness to ovarian cancer, increase the number of survivors in this country, and ultimately save more lives.

  • Become a sponsor of OCRA’s International Gynecologic Cancer Conference
  • Get your brand in front of survivors, decision-makers, healthcare providers, researchers, clinicians, and corporate supporters.
  • Show your commitment to women and give power to the voice of cancer survivors.
  • Strengthen your brand by educating women about risk, symptoms, and prevention, and highlighting your support of Ovarian Cancer Research Alliance.
  • Drive new customers and supporters to your company and Ovarian Cancer Research Alliance through strategic marketing, branding, and partnerships.
  • Increase brand recognition with our supporters.
  • Raise funds to save more lives.

View Sponsorship Opportunities

Questions about Sponsorship?
Please contact Elizabeth White at elizabeth@meetingexpert.org.

Get in Touch

For more information or questions about OCRA’s International Gynecologic Cancer Conference, please email us at conference@ocrahope.org.

For more information about sponsoring, please contact Elizabeth White at elizabeth@meetingexpert.org.

For press inquiries, please contact Amanita Duga-Carroll, ADC Strategic Communications, Inc., at adcstrategiccomms@gmail.com or (917) 597-7880.

View Past Presentations

Videos from OCRA’s 2025 conference are available to watch online. View the full suite of videos on OCRA’s YouTube channel.

Related Topics

The Overview: July 2026

The Overview: July 2026

SummeRun Raises $260,000+ for Research, Hope and Progress Nearly one thousand runners, walkers, survivors, families, friends, and supporters showed up at Seattle’s Seward Park on Sunday, July 12th, for the 33rd annual Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $260,000 for research and programs that support the gynecologic cancer community. The … Continued

Read more

The Overview: June 2026

The Overview: June 2026

Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session. Learn … Continued

Read more

OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research

OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research

Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised more than $260,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.